Skip to content

Exosomes alterations following electroconvulsive therapy in depression

Exosomes alterations following electroconvulsive therapy in depression

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044323
Enrollment
Unknown
Registered
2021-03-16
Start date
2021-03-17
Completion date
Unknown
Last updated
2021-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Depression cases:electroconvulsive therapy

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patient aged 18 to 60 years; 2. Patient met the following DSM-5 criteria for diagnosis of unipolar or bipolar depression; 3. Patient was competent to provide informed consent; 4. Patient was sufficiently fluent in Chinese to ensure valid responses to the neuropsychological tests.

Exclusion criteria

Exclusion criteria: 1. Failure to respond to earlier ECT; 2. ECT within the last 3 months; 3. Rapid-cycling, mixed-episode or manic bipolar disorder; 4. Inability to follow the study protocol; 5. Unstable, serious comorbid medical condition (Parkinsons disease, multiple sclerosis, stroke, alcohol use disorder, etc.) or history of epilepsy; 6. Pregnancy or women without adequate contraception.

Design outcomes

Primary

MeasureTime frame
Montgomery-Asberg Depression Rating Scale;

Secondary

MeasureTime frame
Hamilton anxiety rating scale;Patient Health Questionnaire (PHQ-9);Generalised Anxiety Disorder Assessment (GAD-7);Clinical Global Impression;mini-mental state examination;repeatable battery for the assessment of neuropsyehological status, RBANS;Young manic rating scale;

Countries

China

Contacts

Public ContactZhong-Chun Liu

Wuhan University People's Hospital

zcliu6@whu.edu.cn+86 13871143926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026